Lipocine Inc.

LPCN chart

Lipocine Inc. news

• Lipocine begins phase 3 trial for postpartum depression drug By Investing.com

  Investing.com Nigeria · Nov 10, 9:12 AM EST

• Lipocine Doses First Participant in BLOOM Phase 3 Study of LPCN 1154 for Postpartum Depression

  Yahoo Finance · Nov 10, 8:00 AM EST

• Earnings To Watch: Lipocine Inc (LPCN) Q3 2026 -- GF Value Sees 98% Upside

  GuruFocus · Nov 10, 7:53 AM EST

• Lipocine Says Topline Results From Bloom Study Expected In Second Half of 2027

  TradingView · Nov 10, 6:54 AM EST

• Lipocine Initiates Phase 3 BLOOM Study for Postpartum Depression

  TipRanks · Nov 10, 6:32 AM EST

• Form 8K Lipocine Inc For: 10 November By Investing.com

  Investing.com Canada · Nov 10, 6:20 AM EST

• Lipocine Doses First Participant in Phase 3 BLOOM Study of LPCN 1154

  TradingView · Nov 10, 6:13 AM EST

• Weekly Recap: BLOOM Phase 3 trial begins and Q3 revenue rises

  TradingView · Nov 9, 6:00 AM EST

• Lipocine Stock Price Forecast. Should You Buy LPCN?

  StockInvest.us · Nov 6, 5:29 PM EST

• Lipocine Inc reports results for the quarter ended September 30 - Earnings Summary

  TradingView · Nov 5, 1:16 PM EST

• Lipocine Reports $2.3 Million Q3 Revenue and $0.7 Million Net Loss

  TradingView · Nov 5, 9:43 AM EST

• Lipocine 3Q 2026: Revenue $2.29M, EPS ($0.08) — 10-Q Summary

  TradingView · Nov 5, 9:41 AM EST

Lipocine Inc. key financials

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

• 8-K8-K2026-11-10
• 8-K8-K2026-11-05
• 10-Q10-Q2026-11-05
• 8-K8-K2026-10-20
• 8-K8-K2026-10-07
• 8-K8-K2026-09-16
• 8-K8-K2026-09-14
• 8-K8-K2026-09-11
• 8-K8-K2026-09-10
• 8-K/A8-K/A2026-08-21
• 8-K8-K2026-08-04
• 10-Q10-Q2026-08-04

About Lipocine Inc.

Ticker

LPCN (Nasdaq)

Industry

Pharmaceutical Preparations

Headquarters

Salt Lake City, United States

Incorporated in

DE

Fiscal year end

December 31

SEC CIK

1535955

Former names

MARATHON BAR CORP

Frequently asked questions